Aspiration & Biopsy Needles Market Early Detection, Precise Diagnosis 2024-2031

Aspiration & Biopsy Needles Market worth $1751.18 Mn by 2031 - Exclusive Report by InsightAce Analytic Pvt. Ltd.

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Aspiration & Biopsy Needles Market- (By Product (Biopsy Needle (Core Biopsy Needles, Vacuum-Assisted Biopsy Needles), Aspiration Needle), By Application (Tumor/Cancer Application (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer,

Kidney Cancer, Bone & Bone Marrow Cancer, Other Cancers), Wound Applications, Other Applications), By Procedure (Image-Guided (Ultrasound-Guided Procedures, Stereotactic Procedures, CT-Guided Procedures, MRI -Guided Procedures, Other Image-Guided Procedures), Non-image-guided), By End-User (Hospitals & Surgical Centers,

Ambulatory Care Centers, Diagnostic Clinics & Pathology Laboratories, Research & Academic Institutes)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."

According to the latest research by InsightAce Analytic, the Global Aspiration & Biopsy Needles Market is valued at US$ 925.84 Mn in 2022, and it is expected to reach US$ 1751.18 Mn by 2031, with a CAGR of 7.5% during the forecast period of 2024-2031.

Get a free sample copy of the report: https://www.insightaceanalytic.com/request-sample/1989

Aspiration and Biopsy Needle Market Driven by Growing Cancer Concerns
The aspiration and biopsy needle market is experiencing significant growth due to several key factors:
• Rising cancer incidence: The National Cancer Institute (NCI), the leading U.S. government agency for cancer research, reports an alarming increase in various cancers, including breast, lung, prostate, colon, , kidney, leukemia, thyroid, pancreatic, liver, and bladder cancers.

• Shifting preferences towards minimally invasive procedures: Patients and healthcare providers are increasingly opting for less intrusive treatments and biopsies, driving demand for aspiration and biopsy needles.

• Heightened cancer awareness: Government and international health organizations are playing a crucial role in raising public awareness about cancer. This increased awareness translates to a greater demand for early detection and diagnosis, which often involves needle-based procedures.

Cancer Prevalence by Type and Gender
The NCI report further highlights variations in cancer prevalence by gender:
• Men: Prostate, colorectal, and lung cancers represent an estimated 43% of all male cancer cases.

• Women: Breast, colorectal, and lung cancers are expected to account for roughly half of all new cancer diagnoses in women for 2020.

Impact of Demographics:
Developed nations with higher living standards and longer lifespans tend to exhibit a higher incidence of cancer. This demographic trend further amplifies the need for advanced and efficient diagnostic tools like aspiration and biopsy needles.

Overall, the combined factors of rising cancer rates, a preference for minimally invasive procedures, and growing cancer awareness are creating a strong growth trajectory for the aspiration and biopsy needle market.

List of Prominent Players in the Aspiration & Biopsy Needles Market:
• CONMED Corporation (US)
• Medtronic Plc (Ireland)
• Olympus Corporation (Japan)
• Becton, Dickinson and Company (US)
• Boston Scientific Corporation (US)
• Cook Group Incorporated (US)
• Argon Medical Devices, Inc (US)
• INRAD Inc. (US)
• Somatex Medical Technologies (Germany)
• Stryker Corporation (US)
• Cardinal Health (US)
• Remington Medical (US)
• Rantac Corporation (US)
• HAKKO CO., LTD (Japan)
• Merit Medical Systems (US)

Market Dynamics:
Drivers-
The figure of persons who have cancer has significantly increased on a global scale. Numerous elements, including alterations in the way of life, unhealthful eating patterns, and rising cigarette use, can be blamed for this. Worldwide, there were 17.0 Mn new cases of cancer & 9.5 Mn cancer-related deaths in 2018, as per estimates from the International Agency for Research on Cancer (IARC). The world's cargo of cancer is estimated to increase to 27.5 Mn fresh cases &16.3 Mn deaths by 2040, mostly as a result of population ageing and expansion.

Challenges:
Radiologists and surgeons utilize biopsy needle techniques such as core and fine-needle procedures to check anomalies at a specific location. The drawback of these treatments is that because tissue samples must be removed through cuts and incisions, patients may become infected while receiving them.

Furthermore, there is a high chance of infection during aspiration and biopsy procedures due to the frequent reuse of needles. Healthcare practitioners and product manufacturers do not recommend the reuse of various needles, yet it is nonetheless frequent, especially in developing countries.

Regional Trends:
Asia Pacific accounted for the fastest CAGR in the global aspiration & biopsy needles market due to rising healthcare infrastructure investments and government-led campaigns to raise cancer awareness. Other important aspects contributing to the market's revenue growth include rising government and insurance organization initiatives for cancer diagnostics and screening and rising research activity.

Due to fast urbanization and population growth, which has led to a rapid rise in cancer occurrence, emerging economies like China, India, and South Korea are anticipated to be high-growing prospective markets.

Curious about this latest version of the report? @ https://www.insightaceanalytic.com/enquiry-before-buying/1989

Recent Developments:
• In July 2023, Endoscopy clinical division of Cook Medical announces the launch of the EchoTip ProCore® 20 gauge needle with ReCoil StyletTM, the newest addition to the EchoTip ProCore® product portfolio. The flexible design of this needle enables physicians to acquire histological samples from challenging anatomical locations1.

• In Jan 2021, SOMATEX Medical Technologies GmbH was acquired by Hologic, Inc. for about $64 Mn, according to the company's announcement. SOMATEX provided Hologic with additional knowledge and skills to continue expanding its breast health portfolio by specialising in the development and production of minimally invasive devices in the fields of cancer diagnosis, biopsy, and interventional specialty.

Segmentation of Aspiration & Biopsy Needles Market-
By Product-
• Biopsy Needle
o Core Biopsy Needles
o Vacuum-Assisted Biopsy Needles
• Aspiration Needle

By Application-
• Tumor/Cancer Application
o Breast Cancer
o Lung Cancer
o Colorectal Cancer
o Prostate Cancer
o Kidney Cancer
o Bone & Bone Marrow Cancer
o Other Cancers
• Wound Applications
• Other Applications

By Procedure-
• Image-Guided
o Ultrasound-Guided Procedures
o Stereotactic Procedures
o CT-Guided Procedures
o MRI -Guided Procedures
o Other Image-Guided Procedures
• Non-image-guided

By End-User-
• Hospitals & Surgical Centers
• Ambulatory Care Centers
• Diagnostic Clinics & Pathology Laboratories
• Research & Academic Institutes

By Region-
North America-
• The US
• Canada
• Mexico

Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe

Asia-Pacific-
• China
• Japan
• India
• South Korea
• South East Asia
• Rest of Asia Pacific

Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of the Middle East and Africa

For More Customization @ https://www.insightaceanalytic.com/report/aspiration--biopsy-needles-market/1989

Contact Us:
InsightAce Analytic Pvt. Ltd.
Tel.: +1 718 593 4405
Email: info@insightaceanalytic.com
Site Visit: www.insightaceanalytic.com
Follow Us on LinkedIn @ bit.ly/2tBXsgS
Follow Us On Facebook @ bit.ly/2H9jnDZ

About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions.
Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses.
We help clients gain a competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets, and repositioning products.
Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

This release was published on openPR.